BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 31408913)

  • 1. Acceptability, tolerability, and safety of fecal microbiota transplantation in patients with active ulcerative colitis (AT&S Study).
    Sood A; Singh A; Mahajan R; Midha V; Mehta V; Gupta YK; Narang V; Kaur K
    J Gastroenterol Hepatol; 2020 Mar; 35(3):418-424. PubMed ID: 31408913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early fecal microbiome transfer after donor defecation determines response in patients with moderate to severe ulcerative colitis.
    Singh A; Mahajan R; Kahlon BK; Dhaliwal AS; Midha V; Mehta V; Bansal N; Singh D; Sood A
    Indian J Gastroenterol; 2022 Aug; 41(4):389-396. PubMed ID: 36121613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial.
    Costello SP; Hughes PA; Waters O; Bryant RV; Vincent AD; Blatchford P; Katsikeros R; Makanyanga J; Campaniello MA; Mavrangelos C; Rosewarne CP; Bickley C; Peters C; Schoeman MN; Conlon MA; Roberts-Thomson IC; Andrews JM
    JAMA; 2019 Jan; 321(2):156-164. PubMed ID: 30644982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy and safety of monotherapy with a single fresh fecal microbiota transplant for recurrent active ulcerative colitis: a prospective randomized pilot study.
    Fang H; Fu L; Li X; Lu C; Su Y; Xiong K; Zhang L
    Microb Cell Fact; 2021 Jan; 20(1):18. PubMed ID: 33468164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of single fecal microbiota transplantation for Japanese patients with mild to moderately active ulcerative colitis.
    Nishida A; Imaeda H; Ohno M; Inatomi O; Bamba S; Sugimoto M; Andoh A
    J Gastroenterol; 2017 Apr; 52(4):476-482. PubMed ID: 27730312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal Microbiota Transplantation for Ulcerative Colitis: The Optimum Timing and Gut Microbiota as Predictors for Long-Term Clinical Outcomes.
    Li Q; Ding X; Liu K; Marcella C; Liu X; Zhang T; Liu Y; Li P; Xiang L; Cui B; Wang J; Bai J; Zhang F
    Clin Transl Gastroenterol; 2020 Aug; 11(8):e00224. PubMed ID: 32955197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial.
    Moayyedi P; Surette MG; Kim PT; Libertucci J; Wolfe M; Onischi C; Armstrong D; Marshall JK; Kassam Z; Reinisch W; Lee CH
    Gastroenterology; 2015 Jul; 149(1):102-109.e6. PubMed ID: 25857665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pectin enhances the effect of fecal microbiota transplantation in ulcerative colitis by delaying the loss of diversity of gut flora.
    Wei Y; Gong J; Zhu W; Tian H; Ding C; Gu L; Li N; Li J
    BMC Microbiol; 2016 Nov; 16(1):255. PubMed ID: 27809778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Siderophore-harboring gut bacteria and fecal siderophore genes for predicting the responsiveness of fecal microbiota transplantation for active ulcerative colitis.
    Yan J; Zhou G; Ren R; Zhang X; Zhang N; Wang Z; Peng L; Yang Y
    J Transl Med; 2024 Jun; 22(1):589. PubMed ID: 38915068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal microbiota transplantation is a rescue treatment modality for refractory ulcerative colitis.
    Uygun A; Ozturk K; Demirci H; Oger C; Avci IY; Turker T; Gulsen M
    Medicine (Baltimore); 2017 Apr; 96(16):e6479. PubMed ID: 28422836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidonor FMT capsules improve symptoms and decrease fecal calprotectin in ulcerative colitis patients while treated - an open-label pilot study.
    Cold F; Browne PD; Günther S; Halkjaer SI; Petersen AM; Al-Gibouri Z; Hansen LH; Christensen AH
    Scand J Gastroenterol; 2019 Mar; 54(3):289-296. PubMed ID: 30946615
    [No Abstract]   [Full Text] [Related]  

  • 12. Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis.
    Paramsothy S; Nielsen S; Kamm MA; Deshpande NP; Faith JJ; Clemente JC; Paramsothy R; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Lin E; Borody TJ; Wilkins MR; Colombel JF; Mitchell HM; Kaakoush NO
    Gastroenterology; 2019 Apr; 156(5):1440-1454.e2. PubMed ID: 30529583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis.
    Rossen NG; Fuentes S; van der Spek MJ; Tijssen JG; Hartman JH; Duflou A; Löwenberg M; van den Brink GR; Mathus-Vliegen EM; de Vos WM; Zoetendal EG; D'Haens GR; Ponsioen CY
    Gastroenterology; 2015 Jul; 149(1):110-118.e4. PubMed ID: 25836986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis.
    Kunde S; Pham A; Bonczyk S; Crumb T; Duba M; Conrad H; Cloney D; Kugathasan S
    J Pediatr Gastroenterol Nutr; 2013 Jun; 56(6):597-601. PubMed ID: 23542823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal microbiota transplantation for ulcerative colitis.
    Matsuoka K
    Immunol Med; 2021 Mar; 44(1):30-34. PubMed ID: 32663072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Step-up fecal microbiota transplantation strategy: a pilot study for steroid-dependent ulcerative colitis.
    Cui B; Li P; Xu L; Zhao Y; Wang H; Peng Z; Xu H; Xiang J; He Z; Zhang T; Nie Y; Wu K; Fan D; Ji G; Zhang F
    J Transl Med; 2015 Sep; 13():298. PubMed ID: 26363929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of fecal microbiota transplantation
    Tkach S; Dorofeyev A; Kuzenko I; Falalyeyeva T; Tsyryuk O; Kovalchuk O; Kobyliak N; Abenavoli L; Boccuto L
    Front Med (Lausanne); 2022; 9():1049849. PubMed ID: 36714101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in Intestinal Microbiota Following Combination Therapy with Fecal Microbial Transplantation and Antibiotics for Ulcerative Colitis.
    Ishikawa D; Sasaki T; Osada T; Kuwahara-Arai K; Haga K; Shibuya T; Hiramatsu K; Watanabe S
    Inflamm Bowel Dis; 2017 Jan; 23(1):116-125. PubMed ID: 27893543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
    Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
    PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal Microbiota Transplantation for Ulcerative Colitis: A Systematic Review and Meta-Analysis.
    Shi Y; Dong Y; Huang W; Zhu D; Mao H; Su P
    PLoS One; 2016; 11(6):e0157259. PubMed ID: 27295210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.